Tompkins Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
CIM
Tompkins Financial's BIIB Position: Q3 2026 in Review
Tompkins Financial held its Biogen (BIIB) position steady in Q3 2026 at 2,200 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #132.
Tompkins Financial first reported a position in BIIB in Q4 2013 and has held it in 19 quarters since. 126 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Tompkins Financial held 2,200 shares of Biogen worth $497K as of Q3 2026.
- Tompkins Financial left its Biogen share count unchanged in Q3 2026.
- Biogen made up 0.04% of Tompkins Financial's portfolio in Q3 2026, its #132 holding.
- Tompkins Financial first reported a position in Biogen in Q4 2013 and has held it in 19 quarters since.
- 126 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Tompkins Financial's 13F filing for Q3 2026, filed 5 Oct 2026.